Search Results 2441-2450 of 18225 for rheumatoid arthritis

  1. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

    ... factor, granulocyte/macrophage colony stimulating factor, or recombinant erythropoietin) within 30 days prior to the start of Screening. History of allergy ...

  2. Study of TJ011133 in Participants With Relapsed/ Refractory Advanced Solid Tumors and Lymphoma - Mayo Clinic

    Participation eligibility · Part 1 · Absolute neutrophil count ≥ 1500/μL (≥ 1.5 × 10^9 /L) without growth factor support for 7 days (14 days if on pegfilgrastim); ...

  3. weight-loss surgery Archives - Mayo Clinic News Network

    Alzheimer's: Gratitude is the one pill everyone should be prescribed · Nutrition-wise: Does diet have a role in rheumatoid arthritis? Living with diabetes: ...

  4. A Study to Evaluate Autologous Adipose Derived Mesenchymal Stem Cells to Treat Spinal Cord Injury Patients - Mayo Clinic

    Taking anti-rheumatic disease medication (including methotrexate or other antimetabolites) within 3 months prior to study enrollment. Ongoing infectious ...

  5. Publications - Leslie V. Simon, D.O. - Mayo Clinic

    Testosterone Therapy as an Isolated Risk Factor for Venous Thrombosis: A Case Report. Cureus. 2024 Jul; 16 (7):e63611 Epub 2024 July 01. View PubMed; Bragg K ...

  6. Hand transplant - Doctors & Departments - Mayo Clinic

    ... arthritis, Nerve entrapment, Broken elbow, Elbow instability, Broken hand, Avascular necrosis, Nonunion. Show more areas of focus for Peter C. Rhee, D.O. ...

  7. Efficacy and Safety of Seralutinib in Adult Subjects With PAH - Mayo Clinic

    Tyrosine kinase inhibitors, other than Janus kinase inhibitors approved for systemic autoimmune rheumatic diseases, within 12 weeks prior to Screening. 2 ...

  8. Publications - Sher-Lu Pai, M.D. - Mayo Clinic

    ... Factor Analysis From 7 Academic Centers in the United States. Anesth Analg. 2021 Jan; 132 (1):130-139. View PubMed; Porter SB, Hughes AJ, Ball CT, Hex KO ...

  9. A Study to Evaluate KD025 in Subjects with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

    Diagnosis of dcSSc according to the 2013 American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) criteria. Must have disease ...

  10. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

    Male or female subjects must be ≥18 years of age. · Subjects must have a diagnosis of SSc as defined by the 2013 American College of Rheumatology criteria/EULAR ...